ProShare Advisors LLC Has $11.17 Million Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

ProShare Advisors LLC lowered its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 6.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 923,146 shares of the pharmacy operator’s stock after selling 68,189 shares during the period. ProShare Advisors LLC owned 0.11% of Walgreens Boots Alliance worth $11,165,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of WBA. Capital World Investors raised its holdings in Walgreens Boots Alliance by 57.5% in the 1st quarter. Capital World Investors now owns 29,061,021 shares of the pharmacy operator’s stock valued at $630,334,000 after buying an additional 10,612,373 shares during the last quarter. Thompson Siegel & Walmsley LLC raised its stake in shares of Walgreens Boots Alliance by 98.8% during the second quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock valued at $72,826,000 after acquiring an additional 2,992,648 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. lifted its holdings in shares of Walgreens Boots Alliance by 6.1% during the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 2,718,659 shares of the pharmacy operator’s stock worth $32,882,000 after purchasing an additional 156,484 shares during the period. Newport Trust Company LLC bought a new stake in shares of Walgreens Boots Alliance in the second quarter worth $31,028,000. Finally, Schroder Investment Management Group increased its holdings in Walgreens Boots Alliance by 1.2% in the fourth quarter. Schroder Investment Management Group now owns 2,249,654 shares of the pharmacy operator’s stock valued at $58,738,000 after purchasing an additional 27,634 shares during the period. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Down 1.7 %

Shares of WBA stock opened at $8.56 on Tuesday. The company has a 50 day moving average of $10.23 and a 200-day moving average of $14.59. Walgreens Boots Alliance, Inc. has a 12-month low of $8.46 and a 12-month high of $27.05. The firm has a market cap of $7.39 billion, a P/E ratio of -1.27, a PEG ratio of 1.02 and a beta of 0.70. The company has a quick ratio of 0.31, a current ratio of 0.65 and a debt-to-equity ratio of 0.49.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing the consensus estimate of $0.68 by ($0.05). Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The company had revenue of $36.40 billion for the quarter, compared to the consensus estimate of $35.94 billion. During the same quarter in the prior year, the company earned $1.00 earnings per share. The company’s quarterly revenue was up 2.8% on a year-over-year basis. Sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 2.86 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, September 12th. Investors of record on Wednesday, August 21st were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 11.68%. The ex-dividend date of this dividend was Wednesday, August 21st. Walgreens Boots Alliance’s dividend payout ratio is currently -14.84%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on WBA shares. Bank of America reduced their price target on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research report on Wednesday, September 4th. Morgan Stanley decreased their target price on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating for the company in a research report on Friday, June 28th. JPMorgan Chase & Co. reduced their price objective on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research note on Friday, August 30th. Barclays lowered their target price on shares of Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating for the company in a research note on Tuesday, July 23rd. Finally, UBS Group cut their price target on shares of Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 3rd. Four equities research analysts have rated the stock with a sell rating, ten have given a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Walgreens Boots Alliance has an average rating of “Hold” and a consensus price target of $14.73.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.